Related Experiment Video
Updated: Oct 18, 2025
06:50
Extraction and Analysis of Taiwanese Green Propolis
Published on: January 7, 2019
8.7K
Stingless Bee Propolis: New Insights for Anticancer Drugs
Jaqueline Ferreira Campos1, Helder Freitas Dos Santos1, Thaliny Bonamigo1
1Research Group on Biotechnology and Bioprospecting Applied to Metabolism (GEBBAM), Federal University of Grande Dourados, Dourados, MS, Brazil.
Oxidative Medicine and Cellular Longevity
|October 4, 2021
Summary
Stingless bee propolis shows significant antitumor potential, acting through apoptosis and necroptosis pathways. Further research is needed to confirm its efficacy and safety as a cancer treatment.
Area of Science:
- Bioprospecting
- Pharmacology
- Natural Products Chemistry
Background:
- Natural products are vital sources of anticancer drug prototypes.
- Tropical biodiversity offers potential for discovering new therapeutic compounds.
- Propolis from stingless bees is a promising candidate for cancer research.
Purpose of the Study:
- To review the anticancer potential of stingless bee propolis.
- To detail chemical compounds, mechanisms of action, and cell death profiles.
- To evaluate propolis as an adjuvant or novel anticancer agent.
Main Methods:
- Literature review of studies on stingless bee propolis.
- Analysis of chemical constituents and their biological activities.
- Examination of molecular mechanisms, including apoptosis and necroptosis.
Main Results:
- Propolis induces antitumor effects via apoptosis (affecting BAX, BAD, BCL2-L1, BCL-2, mitochondrial membrane depolarization, caspase-3 activation, PARP cleavage) and necroptosis (via RIPK1).
- Antioxidant and anti-inflammatory properties of propolis compounds contribute to cancer prevention.
- Identified specific molecular targets and pathways involved in propolis-induced cell death.
Conclusions:
- Stingless bee propolis exhibits considerable antitumor potential.
- Mechanisms involve complex apoptotic and necroptotic pathways.
- Further preclinical and clinical studies are essential to validate propolis's therapeutic value, efficacy, and safety.
More Related Videos
Related Concept Videos
01:15Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
02:34Inhibition of Cdk Activity
5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
02:49Cancer Therapies
8.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.3K
02:59Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
01:10Drugs that Destabilize Microtubules
2.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K